SEC Form 4 · accession 0001415889-18-000106
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Fried
Officer — PRESIDENT, COO, CSO · Director
Period of report
Jan 21, 2018
Accepted (ET)
Jan 23, 2018 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $5.85 | Jan 21, 2018 | A | 300,000 | A | Jan 21, 2018 | Jan 21, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F110/36th of the shares vested on January 21, 2018 and thereafter 1/36th vest on the 12th of each month for the next 26 months.